301 related articles for article (PubMed ID: 31820118)
1. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
Li BK; Vasiljevic A; Dufour C; Yao F; Ho BLB; Lu M; Hwang EI; Gururangan S; Hansford JR; Fouladi M; Nobusawa S; Laquerriere A; Delisle MB; Fangusaro J; Forest F; Toledano H; Solano-Paez P; Leary S; Birks D; Hoffman LM; Szathmari A; Faure-Conter C; Fan X; Catchpoole D; Zhou L; Schultz KAP; Ichimura K; Gauchotte G; Jabado N; Jones C; Loussouarn D; Mokhtari K; Rousseau A; Ziegler DS; Tanaka S; Pomeroy SL; Gajjar A; Ramaswamy V; Hawkins C; Grundy RG; Hill DA; Bouffet E; Huang A; Jouvet A
Acta Neuropathol; 2020 Feb; 139(2):223-241. PubMed ID: 31820118
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study.
Liu APY; Li BK; Pfaff E; Gudenas B; Vasiljevic A; Orr BA; Dufour C; Snuderl M; Karajannis MA; Rosenblum MK; Hwang EI; Ng HK; Hansford JR; Szathmari A; Faure-Conter C; Merchant TE; Levine M; Bouvier N; von Hoff K; Mynarek M; Rutkowski S; Sahm F; Kool M; Hawkins C; Onar-Thomas A; Robinson GW; Gajjar A; Pfister SM; Bouffet E; Northcott PA; Jones DTW; Huang A
Acta Neuropathol; 2021 May; 141(5):771-785. PubMed ID: 33619588
[TBL] [Abstract][Full Text] [Related]
3. Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.
Pfaff E; Aichmüller C; Sill M; Stichel D; Snuderl M; Karajannis MA; Schuhmann MU; Schittenhelm J; Hasselblatt M; Thomas C; Korshunov A; Rhizova M; Wittmann A; Kaufhold A; Iskar M; Ketteler P; Lohmann D; Orr BA; Ellison DW; von Hoff K; Mynarek M; Rutkowski S; Sahm F; von Deimling A; Lichter P; Kool M; Zapatka M; Pfister SM; Jones DTW
Acta Neuropathol; 2020 Feb; 139(2):243-257. PubMed ID: 31768671
[TBL] [Abstract][Full Text] [Related]
4. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
Liu APY; Gudenas B; Lin T; Orr BA; Klimo P; Kumar R; Bouffet E; Gururangan S; Crawford JR; Kellie SJ; Chintagumpala M; Fisher MJ; Bowers DC; Hassall T; Indelicato DJ; Onar-Thomas A; Ellison DW; Boop FA; Merchant TE; Robinson GW; Northcott PA; Gajjar A
Acta Neuropathol; 2020 Feb; 139(2):259-271. PubMed ID: 31802236
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome.
Raleigh DR; Solomon DA; Lloyd SA; Lazar A; Garcia MA; Sneed PK; Clarke JL; McDermott MW; Berger MS; Tihan T; Haas-Kogan DA
Neuro Oncol; 2017 Jan; 19(1):78-88. PubMed ID: 27282397
[TBL] [Abstract][Full Text] [Related]
6. Histopathology and molecular pathology of pediatric pineal parenchymal tumors.
Vasiljevic A
Childs Nerv Syst; 2023 Sep; 39(9):2273-2284. PubMed ID: 35972537
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.
Miller S; Rogers HA; Lyon P; Rand V; Adamowicz-Brice M; Clifford SC; Hayden JT; Dyer S; Pfister S; Korshunov A; Brundler MA; Lowe J; Coyle B; Grundy RG
Neuro Oncol; 2011 Aug; 13(8):866-79. PubMed ID: 21798848
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation.
Ito T; Kanno H; Sato K; Oikawa M; Ozaki Y; Nakamura H; Terasaka S; Kobayashi H; Houkin K; Hatanaka K; Murata J; Tanaka S
World Neurosurg; 2014; 81(5-6):783-9. PubMed ID: 23396072
[TBL] [Abstract][Full Text] [Related]
9. DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis.
von Bueren AO; Gerss J; Hagel C; Cai H; Remke M; Hasselblatt M; Feuerstein BG; Pernet S; Delattre O; Korshunov A; Rutkowski S; Pfister SM; Baudis M
J Neurooncol; 2012 Sep; 109(2):415-23. PubMed ID: 22772606
[TBL] [Abstract][Full Text] [Related]
10. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma.
Lee JC; Mazor T; Lao R; Wan E; Diallo AB; Hill NS; Thangaraj N; Wendelsdorf K; Samuel D; Kline CN; Banerjee A; Auguste K; Raffel C; Gupta N; Berger M; Raleigh DR; Shai A; Phillips JJ; Bollen AW; Tihan T; Perry A; Costello J; Solomon DA
Acta Neuropathol; 2019 May; 137(5):851-854. PubMed ID: 30877433
[No Abstract] [Full Text] [Related]
11. MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.
Jaju A; Hwang EI; Kool M; Capper D; Chavez L; Brabetz S; Billups C; Li Y; Fouladi M; Packer RJ; Pfister SM; Olson JM; Heier LA
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1796-1803. PubMed ID: 31601576
[TBL] [Abstract][Full Text] [Related]
12. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects.
Schild SE; Scheithauer BW; Schomberg PJ; Hook CC; Kelly PJ; Frick L; Robinow JS; Buskirk SJ
Cancer; 1993 Aug; 72(3):870-80. PubMed ID: 8334641
[TBL] [Abstract][Full Text] [Related]
13. Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma.
Snuderl M; Kannan K; Pfaff E; Wang S; Stafford JM; Serrano J; Heguy A; Ray K; Faustin A; Aminova O; Dolgalev I; Stapleton SL; Zagzag D; Chiriboga L; Gardner SL; Wisoff JH; Golfinos JG; Capper D; Hovestadt V; Rosenblum MK; Placantonakis DG; LeBoeuf SE; Papagiannakopoulos TY; Chavez L; Ahsan S; Eberhart CG; Pfister SM; Jones DTW; Karajannis MA
Nat Commun; 2018 Jul; 9(1):2868. PubMed ID: 30030436
[TBL] [Abstract][Full Text] [Related]
14. Pineoblastoma-The Experience at St. Jude Children's Research Hospital.
Parikh KA; Venable GT; Orr BA; Choudhri AF; Boop FA; Gajjar AJ; Klimo P
Neurosurgery; 2017 Jul; 81(1):120-128. PubMed ID: 28327927
[TBL] [Abstract][Full Text] [Related]
15. Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003--a single institution's experience.
Stoiber EM; Schaible B; Herfarth K; Schulz-Ertner D; Huber PE; Debus J; Oertel S
Radiat Oncol; 2010 Dec; 5():122. PubMed ID: 21184689
[TBL] [Abstract][Full Text] [Related]
16. Pineal parenchymal tumors--utility of immunohistochemical markers in prognostication.
Arivazhagan A; Anandh B; Santosh V; Chandramouli BA
Clin Neuropathol; 2008; 27(5):325-33. PubMed ID: 18808064
[TBL] [Abstract][Full Text] [Related]
17. A new pineoblastoma cell line, PER-480, with der(10)t(10;17), der(16)t(1;16), and enhanced MYC expression in the absence of gene amplification.
Kees UR; Spagnolo D; Hallam LA; Ford J; Ranford PR; Baker DL; Callen DF; Biegel JA
Cancer Genet Cytogenet; 1998 Jan; 100(2):159-64. PubMed ID: 9428362
[TBL] [Abstract][Full Text] [Related]
18. Pineal parenchymal tumours: II. On the aggressive behaviour of pineoblastoma in patients with an inherited mutation of the RB1 gene.
Plowman PN; Pizer B; Kingston JE
Clin Oncol (R Coll Radiol); 2004 Jun; 16(4):244-7. PubMed ID: 15214647
[TBL] [Abstract][Full Text] [Related]
19. Comparative genomic hybridization in pineal parenchymal tumors.
Rickert CH; Simon R; Bergmann M; Dockhorn-Dworniczak B; Paulus W
Genes Chromosomes Cancer; 2001 Jan; 30(1):99-104. PubMed ID: 11107183
[TBL] [Abstract][Full Text] [Related]
20. Management and survival of pineoblastoma: an analysis of 34 adults from the brain tumor registry of Japan.
Lee JY; Wakabayashi T; Yoshida J
Neurol Med Chir (Tokyo); 2005 Mar; 45(3):132-41; discussion 141-2. PubMed ID: 15782004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
